Profile data is unavailable for this security.
About the company
Global Pharmatech, Inc., formerly Global Pharmatech Pvt. Ltd., is a contract manufacturer of liquid sterile formulations in small volume glass vials and ampoules, and large volume glass bottles The Company has manufactured products in various therapeutic segments such as Vitamin Supplements, Anaesthetics, Corticosteroids, Anti-emetics, Steroids with antibiotics, Anemia, Analgesics, Antihistamines, Anti Filarial. Its first product, Iron Sucrose, is being marketed in India. It offers the products for domestic as well as international market. Its products include Iron Sucrose Injection USP, Ondansetron Injection USP, Promethazine Injection BP, Tramadol HCI Injection, Metoclopramide Injection BP, Levetiracetam Injection and Amikacin Injection. The Company registers products in various markets around the world.
- Revenue in USD (TTM)3.18m
- Net income in USD-2.24m
- Incorporated2001
- Employees217.00
- LocationGlobal Pharmatech Inc509 Maoxiang StreetHigh-Tech Development AreaCHANGCHUN 130012ChinaCHN
- Phone+86 43 185541826
- Websitehttp://www.globalpharmatech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Odonate Inc | 0.00 | -102.07m | 49.87m | 137.00 | -- | 1,839.01 | -- | -- | -13.59 | -13.59 | 0.00 | 9.27 | 0.00 | -- | -- | 0.00 | -66.98 | -58.36 | -83.00 | -65.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | -- | -- |
| Immix Biopharma Inc | 0.00 | -21.89m | 49.96m | 14.00 | -- | 2.85 | -- | -- | -0.8536 | -0.8536 | 0.00 | 0.6387 | 0.00 | -- | -- | 0.00 | -92.58 | -- | -114.95 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -87.44 | -- | -- | -- |
| Aadi Bioscience Inc | 25.07m | -61.69m | 54.72m | 53.00 | -- | 0.7935 | -- | 2.18 | -2.29 | -2.29 | 0.9285 | 2.80 | 0.2225 | 0.696 | 4.09 | 281,685.40 | -54.75 | -50.25 | -65.27 | -56.15 | 87.39 | -- | -246.06 | -473.97 | 4.54 | -- | 0.00 | -- | 60.06 | 3.85 | -8.68 | -- | 153.54 | -- |
| OptiNose Inc | 75.67m | -31.15m | 55.34m | 132.00 | -- | -- | -- | 0.7313 | -0.2216 | -0.2216 | 0.5416 | -0.2725 | 0.6512 | 0.7659 | 2.96 | 573,272.80 | -26.80 | -48.25 | -- | -98.95 | 90.21 | 86.96 | -41.16 | -131.66 | 0.7198 | -1.61 | 1.48 | -- | -6.93 | 58.64 | 52.58 | -- | -27.96 | -- |
| bluebird bio Inc | 53.12m | -300.52m | 58.76m | 375.00 | -- | -- | -- | 1.11 | -1.84 | -1.84 | 0.3039 | -0.0298 | 0.0985 | 2.03 | 4.42 | 141,653.30 | -55.72 | -34.75 | -96.37 | -40.84 | -43.49 | -124.35 | -565.74 | -5,770.41 | 0.3272 | -13.37 | 1.03 | -- | 720.04 | -11.58 | 8.00 | -- | -30.47 | -- |
| Cellectar Biosciences Inc | 0.00 | -48.74m | 63.28m | 20.00 | -- | 12.33 | -- | -- | -2.51 | -2.51 | 0.00 | 0.3839 | 0.00 | -- | -- | 0.00 | -271.59 | -83.69 | -682.65 | -99.80 | -- | -- | -- | -- | -- | -41.97 | 0.00 | -- | -- | -- | -32.80 | -- | 17.55 | -- |
| Procaps Group SA | 414.10m | 52.20m | 64.48m | 5.50k | 1.10 | 1.64 | 0.9255 | 0.1557 | 0.5209 | 0.5209 | 4.16 | 0.3491 | 0.854 | 1.87 | 3.38 | 75,290.18 | 10.77 | -- | 19.01 | -- | 55.04 | -- | 12.61 | -- | 0.9861 | -- | 0.8829 | -- | 0.0434 | -- | 142.18 | -- | -- | -- |
| Hongchang International Co Ltd | 5.42m | -208.79k | 66.15m | 8.00 | -- | 1.63 | -- | 12.21 | -0.0004 | -0.0004 | 0.0104 | 0.0784 | 0.0991 | 5.50 | 37.20 | -- | -0.2731 | -7.98 | -0.2965 | -10.94 | 4.51 | 11.47 | -2.76 | -64.88 | 4.64 | -- | 0.3169 | -- | 3,289.22 | -- | -42.63 | -- | -- | -- |
| Global Pharmatech Inc. | 3.18m | -2.24m | 67.19m | 217.00 | -- | 0.4959 | -- | 21.13 | -0.0964 | -0.0964 | 0.1367 | 0.3428 | 0.2292 | 1.59 | 3.57 | 14,649.77 | -16.44 | -- | -22.55 | -- | 46.21 | -- | -71.75 | -- | 1.62 | -9.87 | 0.2223 | -- | 32.43 | -- | -142.03 | -- | -- | -- |
| CASI Pharmaceuticals Inc | 22.06m | -30.97m | 70.49m | 176.00 | -- | 5.09 | -- | 3.20 | -2.23 | -2.23 | 1.59 | 1.03 | 0.32 | 0.9265 | 2.03 | 125,312.50 | -43.04 | -34.75 | -66.19 | -46.91 | 54.31 | 55.98 | -134.50 | -153.72 | 2.32 | -- | 0.58 | -- | -21.41 | -- | 34.27 | -- | 14.65 | -- |
| Rockwell Medical Inc | 98.92m | -1.24m | 75.30m | 237.00 | -- | 2.58 | 52.81 | 0.7613 | -0.0496 | -0.0496 | 3.23 | 0.9015 | 1.80 | 14.45 | 10.84 | 417,371.30 | -2.25 | -46.29 | -3.34 | -65.38 | 16.91 | 4.66 | -1.25 | -36.51 | 2.00 | 0.3194 | 0.2654 | -- | 14.84 | 5.69 | 54.82 | -- | 76.21 | -- |
| Journey Medical Corp | 57.77m | -18.34m | 77.87m | 58.00 | -- | 9.92 | -- | 1.35 | -0.9276 | -0.9276 | 2.93 | 0.5271 | 0.889 | 2.16 | 6.19 | 996,051.80 | -28.22 | -- | -76.21 | -- | 57.32 | -- | -31.74 | -- | 1.03 | -13.65 | 0.6582 | -- | 7.48 | -- | 87.00 | -- | -- | -- |
| I-Mab ADR | -100.00bn | -100.00bn | 79.27m | 220.00 | -- | 0.3373 | -- | -- | -- | -- | -- | 2.91 | -- | -- | -- | -- | -- | -35.51 | -- | -41.43 | -- | -- | -- | -509.54 | -- | -- | 0.00 | -- | 111.86 | -13.65 | 44.45 | -- | -5.95 | -- |
Data as of Nov 13 2024. Currency figures normalised to Global Pharmatech Inc's reporting currency: US Dollar USD
